Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 20 citing articles:

Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management
Animesh Pardanani
American Journal of Hematology (2023) Vol. 98, Iss. 7, pp. 1097-1116
Open Access | Times Cited: 60
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management
William Shomali, Jason Gotlib
American Journal of Hematology (2024) Vol. 99, Iss. 5, pp. 946-968
Open Access | Times Cited: 16
The international consensus classification of eosinophilic disorders and systemic mastocytosis
Sa A. Wang, Attilio Orazi, Jason Gotlib, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 8, pp. 1286-1306
Closed Access | Times Cited: 28
Approach to the patient with suspected hypereosinophilic syndrome
Amy D. Klion
Hematology (2022) Vol. 2022, Iss. 1, pp. 47-54
Open Access | Times Cited: 33
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort
Georgia Metzgeroth, Laurenz Steiner, Nicole Naumann, et al.
Leukemia (2023) Vol. 37, Iss. 9, pp. 1860-1867
Open Access | Times Cited: 13
67-Year-Old Man With Syncope
Jenny Jia Ling Cao, Nader Al-Shakarchi, Dayne Voelker
Mayo Clinic Proceedings (2025)
Closed Access
Myeloid/lymphoid neoplasms with eosinophilia and specific gene rearrangements: a genetic approach
Ayşe Gül Bayrak, Aynur Dağlar Aday
Genel Tıp Dergisi (2025) Vol. 35, Iss. 1, pp. 219-221
Open Access
Systemic mastocytosis: 2023 update on diagnosis and management in adults
Alessandro Nanni Costa, Emilia Scalzulli, Ida Carmosino, et al.
Expert Opinion on Emerging Drugs (2023) Vol. 28, Iss. 3, pp. 153-165
Closed Access | Times Cited: 7
Pemigatinib for the treatment of myeloid/lymphoid neoplasms with FGFR1 rearrangement
Craig W. Freyer, Mitchell E. Hughes, Alison Carulli, et al.
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 4, pp. 351-359
Closed Access | Times Cited: 6
Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs
Angelica Pace, Fabio Scirocchi, Chiara Napoletano, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
How to evaluate the patient with a suspected mast cell disorder and how/when to manage symptoms
Cem Akin
Hematology (2022) Vol. 2022, Iss. 1, pp. 55-63
Open Access | Times Cited: 8
Tyrosine Kinase Inhibitors in Non-advanced Systemic Mastocytosis
Cem Akin
Immunology and Allergy Clinics of North America (2023) Vol. 43, Iss. 4, pp. 743-750
Closed Access | Times Cited: 4
Systemic mastocytosis - a common diagnosis for allergists and hematologists
Marie Žemličková, Tomáš Kozák
Vnitřní lékařství (2024) Vol. 70, Iss. 4, pp. 224-232
Open Access
SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic Mastocytosis
Helen T. Chifotides, Prithviraj Bose
Clinical Lymphoma Myeloma & Leukemia (2024)
Closed Access
Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals
Johannes Lübke, Georgia Metzgeroth, Andreas Reiter, et al.
Current Hematologic Malignancy Reports (2024) Vol. 19, Iss. 5, pp. 208-222
Open Access
Imatinib is effective in some PDGFRA/B‐negative hypereosinophilic syndromes: A step closer to unveiling underlying mechanisms
Giuseppe Gaetano Loscocco, Grzegorz Helbig
British Journal of Haematology (2024)
Open Access
Myeloische/lymphatische Neoplasien mit Eosinophilie und Tyrosinkinase-Fusionsgenen
Georgia Metzgeroth, Philipp Ströbel, Andreas Reiter
Deleted Journal (2023) Vol. 29, Iss. 4, pp. 329-338
Closed Access
Peginterferon-alfa-2a

Reactions Weekly (2023) Vol. 1950, Iss. 1, pp. 329-329
Closed Access
Concomitant myeloproliferative neoplasm with eosinophilia, B and T cell lymphoblastic lymphoma/leukemia and mast cell proliferation driven by ZMYM2::FGFR1 rearrangement
Giuseppe Gaetano Loscocco, Stefano Ascani, Francesco Mannelli, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 12, pp. 1959-1962
Closed Access
A Young Man With a Neck Mass and Hypereosinophilia
Maha Hameed, Nasir Bakshi, Mansour Alfayez
JAMA Oncology (2023) Vol. 10, Iss. 1, pp. 129-129
Closed Access
Page 1

Scroll to top